Showing results (191-200 of 248) with videos related to
Sort By:
Pageof 25
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.Journal of the National Cancer Institute|November 4, 2020
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic ReviewHoussein Safa, Monica Tamil, Philippe E Spiess, et al.The Journal of Urology|March 6, 2019
Development of a Goal Elicitation Measure to Support Choice about Urinary Diversion by Patients with Bladder CancerMichael C Leo, Scott M Gilbert, Christopher S Wendel, et al.The Journal of Urology|December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trialTeresa L Kauf, Robert S Svatek, Gilad Amiel, et al.Urology|December 14, 2024
Effects of Socioeconomic Deprivation on UTUC Staging, Mortality, and RecurrenceEric R Wahlstedt, Ajay K Varadhan, John C Wahlstedt, et al.Urologic Oncology|October 15, 2024
Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomyMatthew P Banegas, Maureen O'Keeffe Rosetti, Scott M Gilbert, et al.Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Using Analytic Morphomics to Understand Short-Term Convalescence after Radical CystectomyAmy N Luckenbaugh, Brent K Hollenbeck, Jeffrey S Montgomery, et al.Clinical Genitourinary Cancer|January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed OpportunityJuskaran Chadha, Jacob J Adashek, Heather Jim, et al.Journal of Kidney Cancer and VHL|March 23, 2017
Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case ReportCarolina S Emanuels, Krista D Timmerman, Tabish Aijaz, et al.European Urology Oncology|July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerChristopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.Pageof 25